Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex. |
Barton WA, Tzvetkova-Robev D, Miranda EP, Kolev MV, Rajashankar KR, Himanen JP, Nikolov DB. |
Nat Struct Mol Biol. 2006 Jun;13(6):524-32. Epub 2006 May 28. |
PMID 16732286 |
|
The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells. |
Batard P, Sansilvestri P, Scheinecker C, Knapp W, Debili N, Vainchenker W, Buhring HJ, Monier MN, Kukk E, Partanen J, Matikainen MT, Alitalo R, Hatzfeld J, Alitalo K. |
Blood. 1996 Mar 15;87(6):2212-20. |
PMID 8630381 |
|
A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models. |
Brown JL, Cao ZA, Pinzon-Ortiz M, Kendrew J, Reimer C, Wen S, Zhou JQ, Tabrizi M, Emery S, McDermott B, Pablo L, McCoon P, Bedian V, Blakey DC. |
Mol Cancer Ther. 2010 Jan;9(1):145-56. Epub 2010 Jan 6. |
PMID 20053776 |
|
Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. |
Brown LF, Dezube BJ, Tognazzi K, Dvorak HF, Yancopoulos GD. |
Am J Pathol. 2000 Jun;156(6):2179-83. |
PMID 10854238 |
|
Suppression of Tie-1 in endothelial cells in vitro induces a change in the genome-wide expression profile reflecting an inflammatory function. |
Chan B, Sukhatme VP. |
FEBS Lett. 2009 Mar 18;583(6):1023-8. Epub 2009 Feb 21. |
PMID 19236867 |
|
Receptor tyrosine kinase Tie-1 overexpression in endothelial cells upregulates adhesion molecules. |
Chan B, Yuan HT, Ananth Karumanchi S, Sukhatme VP. |
Biochem Biophys Res Commun. 2008 Jul 4;371(3):475-9. Epub 2008 Apr 28. |
PMID 18448073 |
|
Transcriptional and post-translation regulation of the Tie1 receptor by fluid shear stress changes in vascular endothelial cells. |
Chen-Konak L, Guetta-Shubin Y, Yahav H, Shay-Salit A, Zilberman M, Binah O, Resnick N. |
FASEB J. 2003 Nov;17(14):2121-3. Epub 2003 Sep 18. |
PMID 14500555 |
|
Loss of endothelial Tie1 receptor impairs lymphatic vessel development-brief report. |
D'Amico G, Korhonen EA, Waltari M, Saharinen P, Laakkonen P, Alitalo K. |
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):207-9. Epub 2009 Nov 12. |
PMID 19910638 |
|
Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels. |
Falcon BL, Hashizume H, Koumoutsakos P, Chou J, Bready JV, Coxon A, Oliner JD, McDonald DM. |
Am J Pathol. 2009 Nov;175(5):2159-70. Epub 2009 Oct 8. |
PMID 19815705 |
|
Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. |
Holopainen T, Saharinen P, D'Amico G, Lampinen A, Eklund L, Sormunen R, Anisimov A, Zarkada G, Lohela M, Helotera H, Tammela T, Benjamin LE, Yla-Herttuala S, Leow CC, Koh GY, Alitalo K. |
J Natl Cancer Inst. 2012 Mar 21;104(6):461-75. Epub 2012 Feb 17. |
PMID 22343031 |
|
Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis. |
Jin P, Zhang J, Sumariwalla PF, Ni I, Jorgensen B, Crawford D, Phillips S, Feldmann M, Shepard HM, Paleolog EM. |
Arthritis Res Ther. 2008;10(4):R73. Epub 2008 Jul 1. |
PMID 18593464 |
|
Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas. |
Kaipainen A, Vlaykova T, Hatva E, Bohling T, Jekunen A, Pyrhonen S, Alitalo K. |
Cancer Res. 1994 Dec 15;54(24):6571-7. |
PMID 7987857 |
|
Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer. |
Karlan BY, Oza AM, Richardson GE, Provencher DM, Hansen VL, Buck M, Chambers SK, Ghatage P, Pippitt CH Jr, Brown JV 3rd, Covens A, Nagarkar RV, Davy M, Leath CA 3rd, Nguyen H, Stepan DE, Weinreich DM, Tassoudji M, Sun YN, Vergote IB. |
J Clin Oncol. 2012 Feb 1;30(4):362-71. Epub 2011 Dec 19. |
PMID 22184370 |
|
Expression of vascular endothelial growth factor receptor 3 and Tie1 tyrosine kinase receptor on acute leukemia cells. |
Kivivuori SM, Siitonen S, Porkka K, Vettenranta K, Alitalo R, Saarinen-Pihkala U. |
Pediatr Blood Cancer. 2007 Apr;48(4):387-92. |
PMID 16685739 |
|
The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis. |
Kontos CD, Cha EH, York JD, Peters KG. |
Mol Cell Biol. 2002 Mar;22(6):1704-13. |
PMID 11865050 |
|
Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. |
Korhonen J, Partanen J, Armstrong E, Vaahtokari A, Elenius K, Jalkanen M, Alitalo K. |
Blood. 1992 Nov 15;80(10):2548-55. |
PMID 1384789 |
|
tie-1 protein tyrosine kinase: a novel independent prognostic marker for gastric cancer. |
Lin WC, Li AF, Chi CW, Chung WW, Huang CL, Lui WY, Kung HJ, Wu CW. |
Clin Cancer Res. 1999 Jul;5(7):1745-51. |
PMID 10430078 |
|
A combinatorial role of angiopoietin-1 and orphan receptor TIE1 pathways in establishing vascular polarity during angiogenesis. |
Loughna S, Sato TN. |
Mol Cell. 2001 Jan;7(1):233-9. |
PMID 11172728 |
|
Evidence for heterotypic interaction between the receptor tyrosine kinases TIE-1 and TIE-2. |
Marron MB, Hughes DP, Edge MD, Forder CL, Brindle NP. |
J Biol Chem. 2000 Dec 15;275(50):39741-6. |
PMID 10995770 |
|
Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2. |
Marron MB, Singh H, Tahir TA, Kavumkal J, Kim HZ, Koh GY, Brindle NP. |
J Biol Chem. 2007 Oct 19;282(42):30509-17. Epub 2007 Aug 29. |
PMID 17728252 |
|
Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. |
Mazzieri R, Pucci F, Moi D, Zonari E, Ranghetti A, Berti A, Politi LS, Gentner B, Brown JL, Naldini L, De Palma M. |
Cancer Cell. 2011 Apr 12;19(4):512-26. |
PMID 21481792 |
|
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. |
Oliner J, Min H, Leal J, Yu D, Rao S, You E, Tang X, Kim H, Meyer S, Han SJ, Hawkins N, Rosenfeld R, Davy E, Graham K, Jacobsen F, Stevenson S, Ho J, Chen Q, Hartmann T, Michaels M, Kelley M, Li L, Sitney K, Martin F, Sun JR, Zhang N, Lu J, Estrada J, Kumar R, Coxon A, Kaufman S, Pretorius J, Scully S, Cattley R, Payton M, Coats S, Nguyen L, Desilva B, Ndifor A, Hayward I, Radinsky R, Boone T, Kendall R. |
Cancer Cell. 2004 Nov;6(5):507-16. |
PMID 15542434 |
|
Cell autonomous functions of the receptor tyrosine kinase TIE in a late phase of angiogenic capillary growth and endothelial cell survival during murine development. |
Partanen J, Puri MC, Schwartz L, Fischer KD, Bernstein A, Rossant J. |
Development. 1996 Oct;122(10):3013-21. |
PMID 8898215 |
|
Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody. |
Popkov M, Jendreyko N, McGavern DB, Rader C, Barbas CF 3rd. |
Cancer Res. 2005 Feb 1;65(3):972-81. |
PMID 15705898 |
|
Specific induction of tie1 promoter by disturbed flow in atherosclerosis-prone vascular niches and flow-obstructing pathologies. |
Porat RM, Grunewald M, Globerman A, Itin A, Barshtein G, Alhonen L, Alitalo K, Keshet E. |
Circ Res. 2004 Feb 20;94(3):394-401. Epub 2003 Dec 11. |
PMID 14670840 |
|
Interaction of the TEK and TIE receptor tyrosine kinases during cardiovascular development. |
Puri MC, Partanen J, Rossant J, Bernstein A. |
Development. 1999 Oct;126(20):4569-80. |
PMID 10498691 |
|
The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. |
Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J. |
EMBO J. 1995 Dec 1;14(23):5884-91. |
PMID 8846781 |
|
Abnormal embryonic lymphatic vessel development in Tie1 hypomorphic mice. |
Qu X, Tompkins K, Batts LE, Puri M, Baldwin S. |
Development. 2010 Apr;137(8):1285-95. Epub 2010 Mar 10. |
PMID 20223757 |
|
Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. |
Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, Winderlich M, Nottebaum A, Vestweber D, Deutsch U, Koh GY, Olsen BR, Alitalo K. |
Nat Cell Biol. 2008 May;10(5):527-37. Epub 2008 Apr 20. |
PMID 18425119 |
|
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. |
Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. |
Nature. 1995 Jul 6;376(6535):70-4. |
PMID 7596437 |
|
Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands. |
Seegar TC, Eller B, Tzvetkova-Robev D, Kolev MV, Henderson SC, Nikolov DB, Barton WA. |
Mol Cell. 2010 Mar 12;37(5):643-55. |
PMID 20227369 |
|
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. |
Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, Garkavtsev I, Xu L, Hicklin DJ, Fukumura D, di Tomaso E, Munn LL, Jain RK. |
Cancer Cell. 2004 Dec;6(6):553-63. |
PMID 15607960 |
|
Tie1 attenuation reduces murine atherosclerosis in a dose-dependent and shear stress-specific manner. |
Woo KV, Qu X, Babaev VR, Linton MF, Guzman RJ, Fazio S, Baldwin HS. |
J Clin Invest. 2011 Apr;121(4):1624-35. doi: 10.1172/JCI42040. Epub 2011 Mar 7. |
PMID 21383501 |
|
Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation. |
Yabkowitz R, Meyer S, Black T, Elliott G, Merewether LA, Yamane HK. |
Blood. 1999 Mar 15;93(6):1969-79. |
PMID 10068670 |
|
Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival. |
Yuan HT, Venkatesha S, Chan B, Deutsch U, Mammoto T, Sukhatme VP, Woolf AS, Karumanchi SA. |
FASEB J. 2007 Oct;21(12):3171-83. Epub 2007 May 15. |
PMID 17504972 |
|